Circulating Neutrophil Profiles Undergo a Dynamic Shift during Metabolic Dysfunction-Associated Steatohepatitis (MASH) Progression

• Published in: Biomedicines Vol. 12; no. 5; p. 1105
• Main Authors: Maretti-Mira, Ana C, Salomon, Matthew P, Chopra, Shefali, Yuan, Liyun, Golden-Mason, Lucy
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.05.2024
• Subjects: Apoptosis; Biopsy; Cell activation; Cell division; Cirrhosis; Cytokines; Data processing; Development and progression; Ethylenediaminetetraacetic acid; Fibrosis; Genomics; Health aspects; Inflammation; innate immunity; Leukocytes (neutrophilic); Life span; Liver; Liver cirrhosis; Liver diseases; metabolic dysfunction-associated steatohepatitis (MASH); metabolic dysfunction-associated steatotic liver disease (MASLD); Metabolism; Neutrophils; Transcriptomics; United States > US; transcriptomics; metabolic dysfunction-associated steatohepatitis (MASH); metabolic dysfunction-associated steatotic liver disease (MASLD); innate immunity; inflammation; neutrophils
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines12051105

Neutrophils play a crucial role in host defense against infection. Aberrant neutrophil activation may induce tissue damage via sterile inflammation. Neutrophil accumulation has been identified as a feature of the inflammatory response observed in metabolic dysfunction-associated steatohepatitis (MASH) and has been associated with liver fibrosis and cirrhosis. Here, we performed the transcriptomic analysis of circulating neutrophils from mild and advanced MASH patients to identify the potential mechanism behind neutrophil contribution to MASH progression. Our findings demonstrated that circulating neutrophils from mild and advanced MASH display an increased activated transcriptional program, with the expression of pro-inflammatory factors and an amplified lifespan compared to cells from non-diseased controls. Our results also suggest that MASH progression is associated with a dynamic shift in the profile of circulating neutrophils. In the early stages of MASH, mature neutrophils predominate in the bloodstream. As hepatic inflammation and fibrosis progress, the premature release of immature neutrophils into the circulation occurs. These immature neutrophils exhibit a pro-inflammatory profile that may exacerbate inflammation and promote fibrosis in MASH.